Clinical trials
Prostatic Neoplasms trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
134 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 4 |
| 2007 | 6 |
| 2008 | 6 |
| 2009 | 7 |
| 2010 | 6 |
| 2011 | 5 |
| 2012 | 6 |
| 2013 | 8 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 8 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 12 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 71 |
| Recruiting | 27 |
| Active, not recruiting | 22 |
| Unknown status | 7 |
| Terminated | 5 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Karolinska Institutet | 12 |
| AstraZeneca | 9 |
| Bayer | 8 |
| Janssen Research & Development, LLC | 6 |
| Pfizer | 6 |
| Region Skane | 4 |
| Sanofi | 4 |
| Umeå University | 4 |
| Aragon Pharmaceuticals, Inc. | 3 |
| Ferring Pharmaceuticals | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 134 |
| Neoplasms | 13 |
| Neoplasm Metastasis | 11 |
| Breast Neoplasms | 6 |
| Colorectal Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Urinary Bladder Neoplasms | 3 |
| Adenocarcinoma | 2 |
| Disease | 2 |
| Genital Neoplasms, Male | 2 |
Trials
Showing 1 to 25 of 134. Each trial links to its page on Pharma Observatory.
34 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.